VC firm GV (né Google Ventures) has made another investment in Europe — its seventh — leading a $21 million Series B round for epigenetic sequencing tech company and Cambridge University spin-out, Cambridge Epigenetix. Read More http://ift.tt/1LsT2yI
Thursday, 17 March 2016
Google’s GV leads $21M Series B in bioscience firm Cambridge Epigenetix
VC firm GV (né Google Ventures) has made another investment in Europe — its seventh — leading a $21 million Series B round for epigenetic sequencing tech company and Cambridge University spin-out, Cambridge Epigenetix. Read More http://ift.tt/1LsT2yI
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment